// App-Quantinova.ai

OP010 : Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitis

Researchers

Presenter

  • I Al Bakir

Principal Investigators

  • K Curtius

  • A -M Baker

  • T S O Clarke

  • M Moorghen

  • M Jansen

  • M Rodriguez-Justo

  • S Leedham

  • T Graham

  • A Hart

Medical Centers

  • Queen Mary University of London, Barts Cancer Institute, London, UK

  • St. Mark’s Hospital, Inflammatory Bowel Disease Unit, Harrow, UK

  • St. Mark’s Hospital, Pathology Department, Harrow, UK

  • University College London Hospital, Pathology Department, London, UK

  • Henry Wellcome Building of Genomic Medicine, Wellcome Trust Centre for Human Genetics, Oxford, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved